Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients

BACKGROUND: Hepatitis C virus (HCV) infects more than 71 million people worldwide and chronic HCV infection increases the risk of liver cirrhosis and failure. Haemodialysis (HD) is one of the renal replacement therapies with risk of HCV transmission. Anti-HCV antibodies are the serological screening...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Nephrol
Autors principals: Wong, Xue Zheng, Gan, Chye Chung, Mohamed, Rosmawati, Yahya, Rosnawati, Ganapathy, Shubash, Tan, Soek Siam, Lim, Soo Kun
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7666439/
https://ncbi.nlm.nih.gov/pubmed/33187498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-02154-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars